Skip to main content
. 2010 Dec 22;5(12):e15737. doi: 10.1371/journal.pone.0015737

Figure 1. RB1CC1 is a novel prognostic factor in human breast cancer.

Figure 1

Three hundred twenty-three cases of breast cancer were immunohistochemically evaluated and statistically analyzed relative to the clinical outcomes. Kaplan-Meier survival curves with Log-rank tests were performed for DSS evaluation of (A) RB1CC1, (B) p53, (C) the combination of RB1CC1/RB1/p53, and (D) triple-negative for ER/PR/HER2.